Bio-IT World announced the 2023 Innovative Practices Awards winners. Six projects were honored; companies involved in the winning entries included AbbVie, Inc. Information Research; Bayer G4A; Carenostics; City of Hope; Generate Biomedicines; Hackensack Meridian Health; Higher Steaks; Regeneron Pharmaceuticals; SciBite; and Synthace. The awards ceremony will be held during the opening plenary program on Bio-IT World Conference & Expo in Boston.
Since 2003, Bio-IT World has hosted an elite awards program with the goal of highlighting outstanding examples of how technology innovations and strategic initiatives can be applied to advance life sciences research. This year’s winning projects represent excellence in innovation in the categories of Informatics, Personalized & Translational Medicine, Knowledge Management, Research, Laboratory Technology, and Clinical Diagnostics.
This year, our panel of peer judges was particularly impressed with data commons efforts, augmented design experiments, and proven efforts to streamline and optimize the research progress.
“Each year, the Innovative Practices Awards call out the highest levels of collaboration and creativity,” said Allison Proffitt, Bio-IT World Editorial Director. “This year, our panel of peer judges was particularly impressed with data commons efforts, augmented design experiments, and proven efforts to streamline and optimize the research progress.”
Also Read: Trullion Raises Additional $15 Million to Expand AI-Powered Accounting Technology Portfolio
2023 Bio-IT World Innovative Practices Awards Winners
Here are the six winning groups and their projects, as described in their own words.
AbbVie
Project: AbbVie R&D Convergence Hub (ARCH)
The AbbVie R&D Convergence Hub (ARCH), is driving convergence in AbbVie R&D as a central knowledge platform that brings together harmonized, normalized, and curated data from over 170 internal and external sources. Giving scientists across R&D access to this integrated knowledge platform provides them unparalleled access and potential to extract insights and generate hypotheses in novel and powerful ways. Helping AbbVie’s community of researchers to access this knowledge faster, easier, and in automated ways is leading towards a goal to double the productivity of AbbVie R&D. Ultimately, the ARCH and the applications and utilities developed from it are already helping AbbVie to deliver innovative medicines and solutions to patients.
City of Hope nominated by SciBite Limited
Project: POSEIDON – Precision Oncology Software Environment Interoperable Data Ontologies Network
Precision Oncology Software Environment Interoperable Data Ontologies Network (POSEIDON) is an enterprise-wide data platform developed by The City of Hope Research Informatics and the Center for Precision Medicine to support their precision medicine program. Built on the DNAnexus technology stack with custom features and functionality created by City of Hope Research Informatics, POSEIDON unifies patient data and comprehensive germline and somatic genomic profiling for every patient, supporting data from more than 670,000 patients.
SOURCE: PRWeb